Newstral
Article
Ppacbiztimes.com on 2018-05-18 01:48
Amgen gets FDA approval for migraine drug Aimovig
Related news
- PAmgen drug Kyprolis gets another FDA approvalpacbiztimes.com
- PFDA gives full approval to Amgen leukemia drug Blincytopacbiztimes.com
- PAmgen gets FDA approval for osteoporosis drug Evenitypacbiztimes.com
- MFDA approves anti-migraine drug from Novartis, Amgenmarketwatch.com
- PAmgen clinical trial shows promising results for migraine drug Aimovigpacbiztimes.com
- PAmgen gets approval for arthritis drug biosimilarpacbiztimes.com
- FDA drug approval could revolutionize migraine treatment for millionspost-gazette.com
- Vertex drug gets FDA approvalBoston Herald
- MAmgen gets FDA approval for new cholesterol treatmentmarketwatch.com
- FDA Approves Amgen's Migraine DrugForbes
- Diabetes drug gets FDA sale approvalArkansas Online
- MRegeneron gets FDA approval for Ebola drugmarketwatch.com
- FDA approves Teva migraine drugbizjournals.com
- PFDA approves Amgen heart drugpacbiztimes.com
- Alder BioPharmaceuticals CEO steps down as migraine drug maker nears FDA approvalbizjournals.com
- OptiNose migraine treatment receives FDA approvalbizjournals.com
- PAmgen shares climb after it resubmits Evenity drug application to FDApacbiztimes.com
- PAmgen gets FDA OK to market Repatha’s ability to prevent heart attackspacbiztimes.com
- MNovartis gets FDA panel recommendation for leukemia drug approvalmarketwatch.com
- Radioactive cancer drug at Virginia Mason gets FDA approvalKING 5